[go: up one dir, main page]

SE8601103L - Nya svavelhaltiga 5-substituerade bensimidazol-derivat och forfarande for framstellning derav - Google Patents

Nya svavelhaltiga 5-substituerade bensimidazol-derivat och forfarande for framstellning derav

Info

Publication number
SE8601103L
SE8601103L SE8601103A SE8601103A SE8601103L SE 8601103 L SE8601103 L SE 8601103L SE 8601103 A SE8601103 A SE 8601103A SE 8601103 A SE8601103 A SE 8601103A SE 8601103 L SE8601103 L SE 8601103L
Authority
SE
Sweden
Prior art keywords
benzimidazole derivatives
substituted benzimidazole
preparation
methods
sulfurous
Prior art date
Application number
SE8601103A
Other languages
English (en)
Swedish (sv)
Other versions
SE8601103D0 (sv
Inventor
K Harsanyi
A Maderspach
A Javor
G Hajos
G Fekete
L Szporny
P Tetenyi
K Csomor
E Karpati
B Hegedus
M Kapolnas
M Szollosy
F Kallay
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of SE8601103D0 publication Critical patent/SE8601103D0/xx
Publication of SE8601103L publication Critical patent/SE8601103L/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SE8601103A 1985-03-11 1986-03-10 Nya svavelhaltiga 5-substituerade bensimidazol-derivat och forfarande for framstellning derav SE8601103L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU85892A HU193951B (en) 1985-03-11 1985-03-11 Process for producing new sulfur-containing 5-substituted benzimidazol derivatives and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
SE8601103D0 SE8601103D0 (sv) 1986-03-10
SE8601103L true SE8601103L (sv) 1986-09-12

Family

ID=10951907

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8601103A SE8601103L (sv) 1985-03-11 1986-03-10 Nya svavelhaltiga 5-substituerade bensimidazol-derivat och forfarande for framstellning derav

Country Status (17)

Country Link
US (1) US4814329A (de)
JP (1) JPS61267559A (de)
CN (1) CN86102738A (de)
AT (1) ATA62986A (de)
AU (1) AU5461186A (de)
CH (1) CH672127A5 (de)
DD (1) DD246995A5 (de)
DE (1) DE3608032A1 (de)
DK (1) DK108586A (de)
ES (1) ES8705865A1 (de)
FI (1) FI861002A (de)
FR (1) FR2578541A1 (de)
GB (1) GB2173191B (de)
HU (1) HU193951B (de)
IL (1) IL78111A0 (de)
IT (1) IT1204473B (de)
SE (1) SE8601103L (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3508666A1 (de) * 1985-03-12 1986-09-18 Hoechst Ag, 6230 Frankfurt Heterocyclische disulfide und ihre anwendung als immunmodulatoren
JPS62246587A (ja) * 1986-03-17 1987-10-27 ピ−ピ−ジ−　インダストリイズ，インコ−ポレイテツド 除草活性を有する置換ベンゾオキサゾロン（またはベンゾチアゾロン）化合物
US5098707A (en) * 1989-07-31 1992-03-24 Merck & Co., Inc. Imidazole compounds and their use as transglutaminase inhibitors
US5030644A (en) * 1989-07-31 1991-07-09 Merck & Co., Inc. Imidazole compounds and their use as transglutaminase inhibitors
JP2524420B2 (ja) * 1990-05-16 1996-08-14 明治製菓株式会社 ピペリジン誘導体及びそれらを有効成分とする抗潰瘍剤
EP0474109A1 (de) * 1990-09-03 1992-03-11 Richter Gedeon Vegyeszeti Gyar R.T. Neue 5-Benzyl-substituierte Benzimidazolin-2-Thion-Derivate und Verfahren zu ihrer Herstellung
US5371102A (en) * 1992-03-11 1994-12-06 University Of Hawaii Compositions and methods of inhibiting thyroid activity
US5290801A (en) * 1992-05-29 1994-03-01 The Du Pont Merck Pharmaceutical Company Benzimidazoles for the treatment of atherosclerosis
US5387600A (en) * 1992-07-30 1995-02-07 Fuji Photo Film Co., Ltd. Treating arteriosclerosis using benzimidazole compositions
WO1995034304A1 (fr) * 1994-06-10 1995-12-21 Nauchno-Issledovatelsky Institut Farmakologii Rossiyskoi Akademii Meditsinskikh Nauk Derives de 2-mercaptobenzimidazole pharmacologiquement actifs
ZA962879B (en) * 1995-04-12 1997-03-17 Procter & Gamble A pharmaceutical composition for inhibiting the growth of viruses and cancers
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6288100B1 (en) 1995-06-06 2001-09-11 American Home Products Corporation Benzimidazole derivatives
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US5684030A (en) * 1995-06-07 1997-11-04 American Home Products Corporation 2-substituted benzimidazole derivatives
US5654436A (en) * 1995-06-07 1997-08-05 American Home Products Corporation 2-substituted benzimidazole derivatives
WO1997003970A1 (en) 1995-07-17 1997-02-06 Fuji Photo Film Co., Ltd. Benzimidazole compounds
US5763473A (en) * 1996-12-06 1998-06-09 American Home Procucts Corporation Use of 2-substituted benzimidazole as smooth muscle cell proliferation inhibitors
US5900429A (en) * 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6608096B1 (en) * 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6515074B2 (en) * 2001-01-22 2003-02-04 Delphi Technologies, Inc. Thermoplastic polymer alloy compositions and process for manufacture thereof
DE60221287D1 (de) * 2001-11-08 2007-08-30 Atrium Medical Corp Intraluminale vorrichtung mit einer ein therapeutisches-mittel enthaltenden beschichtung
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US8367099B2 (en) * 2004-09-28 2013-02-05 Atrium Medical Corporation Perforated fatty acid films
WO2006036984A2 (en) * 2004-09-28 2006-04-06 Atrium Medical Corporation Stand-alone film and methods for making the same
WO2006036970A2 (en) * 2004-09-28 2006-04-06 Atrium Medical Corporation Method of thickening a coating using a drug
US8312836B2 (en) 2004-09-28 2012-11-20 Atrium Medical Corporation Method and apparatus for application of a fresh coating on a medical device
US20060088596A1 (en) 2004-09-28 2006-04-27 Atrium Medical Corporation Solubilizing a drug for use in a coating
US20090011116A1 (en) * 2004-09-28 2009-01-08 Atrium Medical Corporation Reducing template with coating receptacle containing a medical device to be coated
US9801982B2 (en) * 2004-09-28 2017-10-31 Atrium Medical Corporation Implantable barrier device
US9427423B2 (en) * 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
AU2006304590A1 (en) 2005-10-15 2007-04-26 Atrium Medical Corporation Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
WO2008057344A2 (en) * 2006-11-06 2008-05-15 Atrium Medical Corporation Coated surgical mesh
US9492596B2 (en) * 2006-11-06 2016-11-15 Atrium Medical Corporation Barrier layer with underlying medical device and one or more reinforcing support structures
WO2010051176A1 (en) * 2008-10-29 2010-05-06 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
EP2593141B1 (de) 2010-07-16 2018-07-04 Atrium Medical Corporation Zusammensetzung und verfahren zur veränderung der geschwindigkeit einer hydrolyse ausgehärteter materialien auf ölbasis
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB634951A (en) * 1947-11-10 1950-03-29 John David Kendall Improvements in or relating to thiazolidone compounds
US2642430A (en) * 1949-04-27 1953-06-16 Monsanto Chemicals Hydroxy substituted aliphatic ether derivatives of nitrogen heterocyclics
DE1214083B (de) * 1964-08-14 1966-04-07 Agfa Gevaert Ag Lichtempfindliches photographisches Material mit mindestens einer lichtempfindlichen Silbersalzemulsionsschicht
FR7303M (de) * 1967-03-07 1969-09-29
JPS5529992B2 (de) * 1972-06-03 1980-08-07
HU169255B (de) * 1973-06-20 1976-10-28
JPS5736278B2 (de) * 1973-09-12 1982-08-03
DE2966575D1 (en) * 1978-06-15 1984-03-01 Monsanto Co Compositions and method for regulating soybean plant growth utilizing substituted benzazolylthioalkanoic acids
DE3216416A1 (de) * 1982-05-03 1983-11-03 Bayer Ag, 5090 Leverkusen Heteroarylthiovinyl-verbindungen, ein verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel
US4492708A (en) * 1982-09-27 1985-01-08 Eli Lilly And Company Antiviral benzimidazoles
GB8313321D0 (en) * 1983-05-14 1983-06-22 Ciba Geigy Ag Preparation of mercaptan substituted carboxylic acids
GB8313322D0 (en) * 1983-05-14 1983-06-22 Ciba Geigy Ag Heterocyclic-(cyclo)aliphatic carboxylic acids
GB8412065D0 (en) * 1984-05-11 1984-06-20 Ciba Geigy Ag Preparation of carboxylic acid derivatives

Also Published As

Publication number Publication date
DD246995A5 (de) 1987-06-24
CH672127A5 (de) 1989-10-31
US4814329A (en) 1989-03-21
SE8601103D0 (sv) 1986-03-10
IT1204473B (it) 1989-03-01
GB8605971D0 (en) 1986-04-16
FI861002A0 (fi) 1986-03-11
ES552896A0 (es) 1987-05-16
GB2173191A (en) 1986-10-08
DK108586D0 (da) 1986-03-10
AU5461186A (en) 1986-10-16
HUT40085A (en) 1986-11-28
IT8619713A0 (it) 1986-03-11
CN86102738A (zh) 1987-10-28
ES8705865A1 (es) 1987-05-16
ATA62986A (de) 1993-02-15
GB2173191B (en) 1989-02-01
JPS61267559A (ja) 1986-11-27
HU193951B (en) 1987-12-28
DE3608032A1 (de) 1986-09-11
DK108586A (da) 1986-09-12
IL78111A0 (en) 1986-07-31
FR2578541A1 (fr) 1986-09-12
FI861002A (fi) 1986-09-12

Similar Documents

Publication Publication Date Title
SE8601103L (sv) Nya svavelhaltiga 5-substituerade bensimidazol-derivat och forfarande for framstellning derav
NL190160C (nl) Piperazinecarboxamide- en -carbothioamidederivaten, werkwijze ter bereiding daarvan, alsmede farmaceutisch preparaat dat een dergelijk derivaat omvat.
ES539266A0 (es) Un procedimiento para la preparacion de nuevas-n-heterociclil-4-piperidinaminas.
ES2018111A6 (es) Procedimiento de preparacion de derivados de 4h-1-benzopiran-4-ona o sus sales.
FI101624B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten N-(3-hydroksi-4-piperidinyyli)(dihydrobentsofuraani-, dihydro-2H-bentsopyraani- tai dihydrobentsodioksiini)karboksamidijohdannaisten valmistamiseksi ja välituote
PT76336A (de) Cephalosporinderivate und verfahren zu ihrer herstellung
ES499870A0 (es) Un procedimiento para la preparacion de derivados de indano
ES520987A0 (es) Procedimiento para la preparacion de derivados de acido espiro (4.(3+n))-2-aza-3carboxilico.
PT77110A (fr) Procede de preparation de nouveaux derives de la xanthine
BR8202861A (pt) Composto composicao farmaceutica processo para baixar a pressao sanguinea de seres humanos processo para preparar um composto e process para preparar uma composicao farmaceutica
DK199789A (da) Anvendelse af et phenylquinolincarboxylsyrederivat eller et farmaceutisk egnet salt deraf til fremstilling af et topisk farmaceutisk praeparat til behandling af hud- og/eller slimepithelsygdomme
PT82512A (fr) Procede de preparation de derives de quinolylglycinamides ayant activite psychotrope et de compositions pharmaceutiques les contenant
FI834702A (fi) Nya nitroalifatiska foereningar, deras framstaellningsfoerfarande och anvaendning.
ES2028838T3 (es) Procedimiento para la obtencion de nuevos derivados de 4,5-hidro-oxazoles.
PT93450A (pt) Processo para a preparacao de novos derivados azetidinicos de acidos piridinocarboxilicos e de composicoes farmaceuticas que os contem
DE3566543D1 (en) 2h-1-benzopyran-2-on derivatives, process for their preparation and medicines containing these compounds
BR8700191A (pt) Derivados de 2-alquilbenzimidazol,compostos,processo para a preparacao dos mesmos,composicoes farmaceuticas e utilizacao dos derivados
FR2580648B1 (fr) Nouveaux derives du triazole, leur procede de preparation et les compositions pharmaceutiques les renfermant
ES554310A0 (es) Un procedimiento para preparar derivados de piridina
FR2572074B1 (fr) Derives du thiadiazole actifs sur le systeme nerveux central, procede d'obtention et compositions pharmaceutiques les contenant
SE8500964L (sv) Aminodiarylsulfoxidderivat, forfarande for framstellning derav och farmaceutiska och pesticidiska kompositioner innehallande desamma
FI820172L (fi) Basiskt substituerade antranilsyror deras framstaellningsfoerfarande och anvaendning
KR910009654A (ko) 아미노피리딘, 아닐린 및 피콜릴아민의 피콜릴셀레노벤즈아미드
ES509154A0 (es) Un procedimiento para la preparacion de nuevos derivados del acido &-glutamil-diaminopimelilo.
PT81066B (pt) Processo para a preparacao de derivados de arfamenina (acido 5-amino-8-guanidino-4-oxo-2-fenilmetil-octanoico) e de composicoes farmaceuticas que os contem

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8601103-8

Effective date: 19900518

Format of ref document f/p: F